Heart failure treatment with beta-blockers, peripheral vascular disease (PVD) and osteoporosis were all put forward for inclusion in the quality framework by the expert review panel, which had worked its way through 153 submissions.
Evidence has shown improved outcomes for heart failure patients given beta-blockers, but the current quality framework only pays GPs for prescribing angiotensin converting enzyme inhibitors.
Another blow to the cardiovascular domains is the omission of PVD. For the second consecutive year the area has been recommended for inclusion. An estimated 60 per cent of patients with the condition will die from an MI and 12 per cent from stroke.
The National Osteoporosis Society (NOS) said that without osteoporosis in the quality framework, the care of 3 million elderly people would be undermined.
The DoH wants quality points for extended hours and not new clinical areas.
* What do you think of the contract breakdown? Complete our Healthcare Republic survey here and get a chance to win 100£ of Amazon vouchers.
Comment below and tell us what you think
See all commented articles in our Forums and Blogs section